financing

News

Strand raises $153m for RNA meds, and other bio financings

Recent financings in biotech include a $153m Series B for programmable mRNA developer Strand, plus rounds for Artbio, Minghui, and Chai Discovery.

News

#InvestinBiotech yearly honeycomb on green background

UK biotech investment "holding firm", says BIA

The UK life sciences raised £1.23bn in venture capital investment in the first half of 2025, although there was a fallback in the second quarter.

News

Daniel Nadler, co-founder and chief executive of OpenEvidence

Medical chatbot firm OpenEvidence raises $210m

OpenEvidence has raised $210m to expand the capabilities of its physician decision-making tool and launch a new service offering 'PhD-level' research.

News

New radiopharma Actithera emerges with $75.5m in financing

A new player in radioligand therapies, Actithera, has arrived on the scene with $75.5m in funding and lead FAP-targeted candidate for cancer.

News

Amid sector disruption, biotech must focus on 'fundamentals'...

The biotech industry in the US is facing a period of deep uncertainty under the Trump administration, but can ride out the storm, says EY.

News

rofessor John Atack and Professor Simon Ward, from Cardiff University’s Medicines Discovery Institute

Welsh biotech Draig emerges with $140m in financing

Draig Therapeutics emerged from the shadows this morning with $140m in funding and a quest to develop new therapies for neuropsychiatric diseases.

Strand raises $153m for RNA meds, and other bio financings

UK biotech investment "holding firm", says BIA

Medical chatbot firm OpenEvidence raises $210m

New radiopharma Actithera emerges with $75.5m in financing

Amid sector disruption, biotech must focus on 'fundamentals'...

Welsh biotech Draig emerges with $140m in financing

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks